Skip to content

Protective role of the deSUMOylating enzyme SENP3 in myocardial ischaemia-reperfusion injury

Research output: Contribution to journalArticle

Original languageEnglish
DateSubmitted - 21 Feb 2019


Interruption of blood supply to the heart is a leading cause of death and disability. However, the molecular events that occur during heart ischaemia, and how these changes prime consequent cell death upon reperfusion, are poorly understood. Protein SUMOylation is a post-translational modification that has been strongly implicated in the protection of cells against a variety of stressors, including ischaemia-reperfusion. In particular, the SUMO2/3-specific protease SENP3 has emerged as an important determinant of cell survival after ischaemic infarct. Here, we used the Langendorff perfusion model to examine changes in the levels and localisation of SUMOylated target proteins and SENP3 in whole heart. We observed a 50% loss of SENP3 from the cytosolic fraction of hearts after preconditioning, a 90% loss after ischaemia and an 80% loss after ischaemia-reperfusion. To examine these effects further, we performed ischaemia and ischaemia-reperfusion experiments in the cardiomyocyte H9C2 cell line. Similar to whole hearts, ischaemia induced a decrease in cytosolic SENP3. Furthermore, shRNA-mediated knockdown of SENP3 led to an increase in the rate of cell death upon reperfusion. Together, our results indicate that cardiac ischaemia dramatically alter levels of SENP3 and suggest that this may a mechanism to promote cell survival after ischaemia-reperfusion in heart.

Download statistics

No data available



  • Full-text PDF (submitted manuscript)

    Rights statement: This is the submitted manuscript (SM). It is also available via bioRxiv at . Please refer to any applicable terms of use of the publisher.

    Submitted manuscript, 1.16 MB, PDF document

    Licence: CC BY

View research connections

Related faculties, schools or groups